MENU
INM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
InMed Pharmaceuticals (INM) Ownership - Who owns InMed Pharmaceuticals?
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
815 West Hastings Street
Phone
+1 604 669-7207
Employees
15
Web
https://www.inmedpharma.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
3.6M
P/E Ratio
0.01
Total Cash
3.42M
Projected Growth
N/A
Total Debt
948.96K
Revenue
4.83M
Risk (Beta)
0.39
Dividend Yield
N/A
Total Cash/Share
2.83
Total Debt/Equity
N/A
Revenue/Share
8.47 USD as % of share price
Fundamentals
INM
Capitalization
3.6M
P/E Ratio
0.01
Risk (Beta)
0.39
Dividend Yield
N/A
Total Cash
3.42M
Total Cash/Share
2.83
Total Debt
949K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
8.47%
Revenue
4.83M
ROE
N/A
Book Value
6.18M
P/B Ratio
0.58
Cash Flow
N/A
Earnings
-12.42
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
84.5M
Current Ratio
3.05
Current Revenue Per Employee
95400.00
Dividends Per Share - Security
N/A
EBITDA
-7.44M
Float
N/A
Float - Current
N/A
Gross Income Margin
41.46
Revenue To Assets
-66.62
Shares Held By Institutions
227K
Shares Outstanding - Current
1.21M
Total Liabilities
2.32M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-35.076
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
815 West Hastings Street
Phone
+1 604 669-7207
Employees
15
Web
https://www.inmedpharma.com